|
Re: Cash burn and the cost of servicing the loan....
|
3
|
Resverlogix Corp.
|
Apr 16, 2018 02:01PM
|
|
Re: This is Great
|
3
|
Resverlogix Corp.
|
Nov 08, 2023 12:44PM
|
|
Re: what of zenith and all our shars we have from that origional invetment?
|
3
|
Resverlogix Corp.
|
Jun 25, 2018 12:06AM
|
|
Re: Is this bad for RVX but right, on the money?
|
3
|
Resverlogix Corp.
|
Apr 18, 2020 06:24PM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
3
|
Zenith Epigenetics
|
Apr 08, 2018 01:16PM
|
|
Re: What If - Uses of Apabetalone
|
3
|
Resverlogix Corp.
|
Aug 11, 2018 07:33PM
|
|
Re: Book closes.....
|
3
|
Resverlogix Corp.
|
Jun 04, 2019 06:15PM
|
|
Re: aberaterone
|
3
|
Zenith Epigenetics
|
Jun 25, 2018 12:25AM
|
|
Re: Apabetalone's impact on blood pressure
|
3
|
Resverlogix Corp.
|
Feb 23, 2019 03:59PM
|
|
Re: Will we see 5 point MACE reduction results in BETONMACE
|
3
|
Resverlogix Corp.
|
Jun 18, 2019 06:17PM
|
|
Re: if the partial sale of zen
|
3
|
Resverlogix Corp.
|
Aug 01, 2024 11:30PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Aug 18, 2019 01:47PM
|
|
Re: Hepalink IPO Document and what it says about RVX
|
3
|
Resverlogix Corp.
|
Jan 27, 2020 03:13AM
|
|
Re: Time
|
3
|
Resverlogix Corp.
|
Aug 22, 2017 06:20PM
|
|
Re: 96 hours
|
3
|
Resverlogix Corp.
|
Aug 22, 2017 06:28PM
|
|
Re: Buyout?......
|
3
|
Resverlogix Corp.
|
Jun 02, 2019 01:09PM
|
|
Re: CANTOS and CIRT
|
3
|
Resverlogix Corp.
|
Nov 13, 2017 11:22PM
|
|
Re: BETonMACE USA vs. non-USA brainstorming
|
3
|
Resverlogix Corp.
|
Nov 21, 2017 02:33AM
|
|
Re: you won’t see anyone buying this
|
3
|
Zenith Epigenetics
|
Dec 06, 2023 12:14PM
|
|
Re: The Time Is Ripe!
|
3
|
Resverlogix Corp.
|
Feb 23, 2019 05:05PM
|
